Anti-gp210 is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against nuclear glycoprotein 210 (gp210) in human serum or plasma. It is used in suspected cases of primary biliary cirrhosis (PBC).
Glycoprotein 210 is a component of the nuclear pore complex. Autoantibodies against gp210 are highly specific to primary biliary cirrhosis and indicate an unfavorable prognosis for the PBC patient.
The primary diagnostic marker for PBC is AMA-M2 detection; however, AMA are absent in some patients. In such cases, complementary detection of antibodies against gp210, Sp100, or centromere can be diagnostically helpful.
Antibodies against gp210 are very rarely also found in patients with autoimmune hepatitis, rheumatoid arthritis, polymyositis, or Sjoegren’s syndrome.


Product Number ORG 256
Tests24 Alegria® strips
Range0 - 100 U/ml
Cut-off10 U/ml
Coating nuclear pore antigen gp210

ORG 722  


Instruction for Use
Safety Data Sheet

Document Archive
Instruction for Use Revision 4. Earlier versions and additional languages can be found in the document archive.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.